Can you interpret the laboratory results, including the complete blood count, for a 69‑year‑old woman with stage 3 chronic kidney disease, diabetes mellitus, hypothyroidism, and recurrent urinary‑tract infections?

Laboratory Interpretation: Mild Normocytic Anemia in Stage 3 CKD

Your complete blood count shows mild normocytic anemia (hemoglobin 11.4 g/dL) that is consistent with your stage 3 chronic kidney disease, and all other cell lines are completely normal, indicating no bone marrow dysfunction or acute hematologic emergency.

Key Findings

Hemoglobin and Red Blood Cells

• Hemoglobin 11.4 g/dL is at the lower limit of normal for women (reference 11.1-15.9 g/dL) 1
• Your hematocrit (34.7%), RBC count (3.86), MCV (90 fL), MCH (29.5 pg), and MCHC (32.9 g/dL) are all within normal ranges
• The normocytic, normochromic pattern (normal MCV and MCHC) is typical of anemia associated with CKD 1
• RDW of 12.4% is normal, suggesting uniform red cell size without iron deficiency or mixed causes

White Blood Cells and Platelets

• WBC count (6.3) and all differential counts are completely normal
• Platelet count (363) is normal
• The fact that all three cell lines are normal rules out bone marrow disorders like myelodysplastic syndrome 2

Clinical Context and Significance

Anemia in Your CKD Stage

With kidney function between 60-80% (stage 3 CKD), mild anemia is expected but not universal 3. The prevalence of anemia increases as kidney function declines, and patients with diabetes develop anemia earlier in CKD progression 1. Your hemoglobin of 11.4 g/dL represents mild anemia that warrants evaluation but not urgent intervention 1.

What These Labs Tell Us About Your Recurrent UTIs

Your normal WBC count and differential do NOT show active infection at the time of this blood draw. The absence of leukocytosis (elevated WBC) or left shift (increased immature granulocytes at 1%) indicates no systemic bacterial infection when tested 1. However, this doesn't exclude:

• Localized bladder infection without systemic response
• Chronic low-grade colonization
• Post-infectious inflammatory state

The normal platelet count argues against severe chronic inflammation that would be expected with ongoing sepsis or systemic infection 4.

Required Additional Testing

Based on KDIGO guidelines for anemia evaluation in CKD, you need the following tests that are NOT included in your current CBC 1, 2, 1:

Iron Studies (Essential)

• Serum ferritin: Target >25 ng/mL in women with CKD 1
• Transferrin saturation (TSAT): Should be >20% 1
• These distinguish iron deficiency (treatable with iron supplementation) from erythropoietin deficiency (may require ESA therapy)

Additional Recommended Tests

• Absolute reticulocyte count: Assesses bone marrow response to anemia 1
• Serum vitamin B12 and folate: Rule out nutritional deficiencies 2
• Kidney function tests: Serum creatinine, estimated GFR, and blood urea nitrogen to confirm current CKD stage 3
• Hemoglobin A1C: As you requested, to assess diabetes control 5

For Your Urinary Symptoms

• Urine albumin-to-creatinine ratio (ACR): First morning void preferred 6, 5
• Urinalysis with microscopy: To detect active infection, hematuria, or pyuria
• Urine culture: If symptomatic, to guide antibiotic therapy 7

Clinical Implications and Next Steps

Anemia Management Algorithm

1. If ferritin <25 ng/mL or TSAT <20%: Trial of iron supplementation (oral for 1-3 months or IV iron) 2
2. If iron replete but Hb remains <11 g/dL with symptoms: Consider erythropoiesis-stimulating agent (ESA) therapy, balancing cardiovascular risks 2
3. Monitor hemoglobin every 3 months in stable CKD stage 3 with diabetes 1

Thyroid Consideration

Given your hypothyroidism history, ensure TSH is optimally controlled (target 0.5-2.5 mIU/L), as both CKD and hypothyroidism independently cause anemia 8, 9, 10. Subclinical hypothyroidism prevalence increases with declining GFR and is associated with worse anemia 10, 11.

UTI and CKD Progression

Recurrent UTIs can accelerate CKD progression through chronic inflammation, tubular injury, and fibrosis 7. Your incomplete bladder emptying symptoms suggest possible:

• Neurogenic bladder (evaluate post-void residual volume)
• Diabetic cystopathy
• Anatomic obstruction requiring imaging 12

Critical Pitfalls to Avoid

1. Do not assume anemia is solely due to CKD without checking iron studies, B12, and folate 1
2. Do not start ESA therapy before correcting iron deficiency 2
3. Do not ignore recurrent UTIs as benign—they may drive CKD progression and require urologic evaluation 7
4. Do not use population-based hemoglobin thresholds rigidly in elderly patients (age 69); individualize based on symptoms and cardiovascular risk 1
5. Ensure thyroid function is optimized before attributing all anemia to CKD 8, 10, 11

Summary of Your Labs

Your CBC shows mild normocytic anemia appropriate for stage 3 CKD with diabetes, normal white blood cells ruling out active systemic infection, and normal platelets indicating adequate bone marrow function. The next diagnostic step is iron studies (ferritin and TSAT), reticulocyte count, B12, folate, updated kidney function tests, and A1C as you requested. Your recurrent UTIs require separate urologic evaluation with imaging and post-void residual measurement to identify reversible causes of incomplete emptying.